The future of Molecular Breast Imaging is low dose and 3D
The future of Molecular Breast Imaging is low dose and 3D
Breast cancer represents 12% of new cancer cases and 25% of all cancers in women. Mammography is the most common modality used for breast imaging. Between 25% and 50% of women (depending on country and ethnic origins) have dense breast tissue, which limits mammography sensitivity.
Molecular Breast Imaging (MBI) is a test that uses a radioactive tracer and special cameras to find breast cancer. Rather than taking a picture of the breast, MBI is a type of functional imaging, meaning that the picture created shows difference in the activity of tissue.
Your source for everything that is going on in Kromek’s world and the industries we work in, delivered right to your inbox.
To gain access to Kromek downloads please enter your email below – shortly after you will receive a verification email. Click the link and Kromek downloads will be unlocked in your browser.
Due to the nature of products we need to ensure that our users are finding the correct information for their needs. By providing your details, you are granting us permission to follow up via email to discuss your needs
